BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Diagnosis
94 results:

  • 1. Hemangioma of the Ilium Simulating bone Metastasis on 18 F-PSMA-1007 PET/CT.
    Dong A; Nian S; Bai Y; Zuo C
    Clin Nucl Med; 2024 Jun; 49(6):e304-e306. PubMed ID: 38377381
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Intra-individual comparison of prostate-specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis.
    Shanmugasundaram R; Saad J; Heyworth A; Wong V; Pelecanos A; Arianayagam M; Canagasingham B; Ferguson R; Goolam AS; Khadra M; Kam J; Ko R; McCombie S; Varol C; Winter M; Mansberg R; Nguyen D; Bui C; Loh H; Le K; Roberts MJ
    BJU Int; 2024 Feb; 133 Suppl 3():25-32. PubMed ID: 37943964
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in Prostate cancer Patients After Definitive Treatment With PSA Level ≤0.2 ng/mL.
    Lu Y; Wilson ZJ; Xu G; Xu Z; Pan T; Wei P
    Clin Nucl Med; 2023 Dec; 48(12):1021-1027. PubMed ID: 37801580
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of parametric imaging and SUV imaging with [
    Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Zhou Y; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):568-580. PubMed ID: 37792025
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hospitalizations and Cost of Inpatient Care for Physical Diseases in Survivors of Childhood cancer in Western Australia: A Longitudinal Matched Cohort Study.
    Abdalla T; Walwyn T; White D; Choong CS; Bulsara M; Preen DB; Ohan JL
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1249-1259. PubMed ID: 37409970
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical Evaluation of
    Zhao L; Wen X; Xu W; Pang Y; Sun L; Wu X; Xu P; Zhang J; Guo Z; Lin Q; Chen X; Chen H
    J Nucl Med; 2023 Aug; 64(8):1210-1217. PubMed ID: 37142301
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Increased
    Liu X; Yan S; Qin X; Cheng K; Zheng J; Wu H; Wei Y; Yuan S
    Skeletal Radiol; 2023 Dec; 52(12):2377-2386. PubMed ID: 37129613
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party.
    Penack O; Peczynski C; Koenecke C; Polge E; Kuhnl A; Fegueux N; Daskalakis M; Kröger N; Dreger P; Besley C; Schanz U; Bloor A; Ganser A; Forcade E; Corral LL; Passweg JR; Novak U; Moiseev I; Schoemans H; Basak GW; Chabannon C; Sureda A; Averbuch D; Glass B; de la Camara R; Peric Z
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072350
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.
    Ljungman P; Tridello G; Piñana JL; Ciceri F; Sengeloev H; Kulagin A; Mielke S; Yegin ZA; Collin M; Einardottir S; Lepretre SD; Maertens J; Campos A; Metafuni E; Pichler H; Folber F; Solano C; Nicholson E; Yüksel MK; Carlson K; Aguado B; Besley C; Byrne J; Heras I; Dignan F; Kröger N; Robin C; Khan A; Lenhoff S; Grassi A; Dobsinska V; Miranda N; Jimenez MJ; Yonal-Hindilerden I; Wilson K; Averbuch D; Cesaro S; Xhaard A; Knelange N; Styczynski J; Mikulska M; de la Camara R
    Front Immunol; 2023; 14():1125824. PubMed ID: 36960069
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.
    Averbuch D; de la Camara R; Tridello G; Knelange NS; Bykova TA; Ifversen M; Dobsinska V; Ayas M; Hamidieh AA; Pichler H; Perez-Martinez A; Cesaro S; Sundin M; Badell I; Bader P; Johansson JE; Mirci-Danicar O; Sedlacek P; Paillard C; Gibson B; Lawson S; Kroeger N; Corbacioglu S; Mikulska M; Piñana JL; Styczynski J; Ljungman P
    Bone Marrow Transplant; 2023 May; 58(5):558-566. PubMed ID: 36849806
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in Ovarian cancer.
    Buehner TM; Liotta M; Potkul RK; Wagner RH; Savir-Baruch B
    Mol Imaging Biol; 2024 Feb; 26(1):45-52. PubMed ID: 36754935
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Role of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and treatment response assessment of primary bone lymphoma.
    Pu Y; Wang C; Xie R; Zhao S; Li K; Yang C; Li J; Xiang A; Wang Y; Chen L; Sun H
    Nucl Med Commun; 2023 Apr; 44(4):318-329. PubMed ID: 36722755
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Unspecific
    Seifert R; Telli T; Opitz M; Barbato F; Berliner C; Nader M; Umutlu L; Stuschke M; Hadaschik B; Herrmann K; Fendler WP
    J Nucl Med; 2023 May; 64(5):738-743. PubMed ID: 36460340
    [No Abstract]    [Full Text] [Related]  

  • 14. Evaluation of 5 Fraction Stereotactic Body Radiation Therapy (SBRT) for Osseous Renal Cell Carcinoma Metastases.
    Dove APH; Wells A; Gong W; Liu D; Kirschner AN
    Am J Clin Oncol; 2022 Dec; 45(12):501-505. PubMed ID: 36413679
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diagnostic Significance of 18F-FDG PET/CT Imaging Coupled with Magnetic Resonance Imaging of the Entire Body for bone Metastases.
    Guo H; Zhang Z; Wang L; Yao S; Xu S; Ma S; Liu S
    Contrast Media Mol Imaging; 2022; 2022():7717398. PubMed ID: 36247843
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. PET Imaging of Fibroblast Activation Protein in Various Types of cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [
    Wu C; Zhang X; Zeng Y; Wu R; Ding L; Xia Y; Chen Z; Zhang X; Wang X
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):194-204. PubMed ID: 36040490
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of [
    Chen H; Pang Y; Li J; Kang F; Xu W; Meng T; Shang Q; Zhao J; Guan Y; Wu H; Xie F; Wang J; Sun L
    Eur Radiol; 2023 Feb; 33(2):1329-1341. PubMed ID: 35976396
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
    Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H
    Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ALNett: A cluster layer deep convolutional neural network for acute lymphoblastic leukemia classification.
    Jawahar M; H S; L JA; Gandomi AH
    Comput Biol Med; 2022 Sep; 148():105894. PubMed ID: 35940163
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.